Teva Pharmaceutical Industries (TEVA) Gross Profit (QoQ) (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) Gross Profit (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.46 Bn 87.60 Bn -
2 Teva Pharmaceutical Industries 35.98 Bn 32.24 Bn 1.97 Bn
3 Zoetis 32.62 Bn 30.68 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn
8 Neurocrine Biosciences 17.78 Bn 16.47 Bn 800.70 Mn
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -25.75%
Dec 31, 2025 15.28%
Sep 30, 2025 9.61%
Jun 30, 2025 11.99%
Mar 31, 2025 -11.50%
Dec 31, 2024 -1.26%
Sep 30, 2024 6.13%
Jun 30, 2024 14.29%
Mar 31, 2024 -26.70%
Dec 31, 2023 30.52%
Sep 30, 2023 3.06%
Jun 30, 2023 13.53%
Mar 31, 2023 -10.62%
Dec 31, 2022 6.05%
Sep 30, 2022 -6.97%
Jun 30, 2022 3.10%
Mar 31, 2022 -15.12%
Dec 31, 2021 14.27%
Sep 30, 2021 -4.22%
Jun 30, 2021 -0.27%